In recent years, colorectal cancer has undergone a troubling epidemiological shift, particularly affecting younger adults who were historically considered low…
In the evolving landscape of breast cancer treatment, hormone receptor-positive (HR+), HER2-negative breast cancer has long presented both opportunities and…
In a groundbreaking development within the realm of genetic medicine, Critical Path Institute’s (C-Path) Critical Path for Alpha-1 Antitrypsin Deficiency…